Skip to main content

Advertisement

Log in

Relationship between glucose exposure via peritoneal dialysis solutions and coronary artery calcification in non-diabetic peritoneal dialysis patients

  • Nephrology – Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Introduction

Vascular calcification is frequent in dialysis patients and is associated with increased mortality. Impaired glucose metabolism is proposed as a contributing factor for vascular calcification. We investigated whether glucose exposure via dialysate may have a role in vascular calcification in non-diabetic peritoneal dialysis patients.

Method

We measured coronary artery calcification by multi-slice computerized tomography in 50 prevalent non-diabetic peritoneal dialysis patients and assessed its relations with fasting blood glucose, homeostasis model assessment of insulin resistance (HOMA-IR), and glucose exposure from peritoneal dialysis fluid.

Results

Twenty-four patients (48%) had no coronary calcification. When patients were grouped according to the presence or absence of calcification, patients with calcification were mostly men and had higher burden of cardiovascular disease history, vitamin D dose intake, serum calcium, total glucose exposure from dialysis solution, and lower total weekly Kt/V urea. In multivariate analysis, dialysate glucose exposure was an independent predictor of coronary artery calcification score, besides serum calcium and Kt/V urea.

Conclusion

These data suggest that high glucose exposure from dialysis solution, which is potentially correctable, is a risk factor for vascular calcification in non-diabetic PD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938–942

    Article  PubMed  CAS  Google Scholar 

  2. Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, Chomka EV, Liu K (2003) Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 107:2571–2576

    Article  PubMed  Google Scholar 

  3. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl 18:1731–1740

    Article  Google Scholar 

  4. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478–1483

    Article  PubMed  CAS  Google Scholar 

  5. Moe SM, O’Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K (2002) Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638–647

    Article  PubMed  Google Scholar 

  6. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695–701

    Article  PubMed  Google Scholar 

  7. Stompór T, Pasowicz M, Sulłowicz W, Dembińska-Kieć A, Janda K, Wójcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E (2003) An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 41:203–211

    Article  PubMed  Google Scholar 

  8. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394–401

    Article  PubMed  CAS  Google Scholar 

  9. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K (2001) Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38:64–69

    Article  PubMed  CAS  Google Scholar 

  10. McCullough PA, Sandberg KR, Dumler F, Yanez JE (2004) Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol 17:205–215

    PubMed  Google Scholar 

  11. Hujairi NM, Afzali B, Goldsmith DJ (2004) Cardiac calcification in renal patients: what we do and don’t know. Am J Kidney Dis 43:234–243

    Article  PubMed  CAS  Google Scholar 

  12. Ammirati AL, Dalboni MA, Cendoroglo M, Draibe SA, Santos RD, Miname M, Canziani ME (2007) The progression and impact of vascular calcification in peritoneal dialysis patients. Perit Dial Int 27:340–346

    PubMed  CAS  Google Scholar 

  13. Chen NX, Duan D, O’Neill KD, Moe SM (2006) High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transpl 21:3435–3442

    Article  CAS  Google Scholar 

  14. Wang CC, Sorribas V, Sharma G, Levi M, Draznin B (2007) Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transport. Atherosclerosis 195:e65–e75

    Article  PubMed  CAS  Google Scholar 

  15. Fadini GP, Pauletto P, Avogaro A, Rattazzi M (2007) The good and the bad in the link between insulin resistance and vascular calcification. Atherosclerosis 193:241–244

    Article  PubMed  CAS  Google Scholar 

  16. Ahmadi N, Tirunagaram S, Hajsadeghi F, Flores F, Saeed A, Hecht H, Naghavi M, Budoff M (2010) Concomitant insulin resistance and impaired vascular function is associated with increased coronary artery calcification. Int J Cardiol 144:163–165

    Article  PubMed  Google Scholar 

  17. Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ (2004) Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 110:803–809

    Article  PubMed  CAS  Google Scholar 

  18. Fortes PC, de Moraes TP, Mendes JG, Stinghen AE, Ribeiro SC, Pecoits-Filho R (2009) Insulin resistance and glucose homeostasis in peritoneal dialysis. Perit Dial Int 29(Suppl 2):S145–S148

    PubMed  CAS  Google Scholar 

  19. Park JT, Chang TI, Kim DK, Lee JE, Choi HY, Kim HW, Chang JH, Park SY, Kim E, Yoo TH, Han DS, Kang SW (2010) Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transpl 25:599–604

    Article  Google Scholar 

  20. Tatar E, Demirci MS, Kircelli F, Gungor O, Turan MN, Sevinc Ok E, Asci G, Ozkahya M, Ok E (2011) Association of insulin resistance with arterial stiffness in nondiabetic peritoneal dialysis patients. Int Urol Nephrol. 2011 Jun 4 [Epub ahead of print]

  21. Holmes CJ (2009) Reducing cardiometabolic risk in peritoneal dialysis patients: role of the dialysis solution. J Diabetes Sci Technol 3:1472–1480

    PubMed  Google Scholar 

  22. Davies SJ, Phillips L, Naish PF, Russell GI (2001) Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12:1046–1051

    PubMed  CAS  Google Scholar 

  23. Twardowski ZJ (1989) Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 7:95–108

    Article  PubMed  CAS  Google Scholar 

  24. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R (1990) Quantification of coronary artery calcification using ultrafast computed tomography. J Am Coll Cardiol 15:827–832

    Article  PubMed  CAS  Google Scholar 

  25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    Article  PubMed  CAS  Google Scholar 

  26. Taniwaki H, Ishimura E, Tabata T, Tsujimoto Y, Shioi A, Shoji T, Inaba M, Inoue T, Nishizawa Y (2005) Aortic calcification in haemodialysis patients with diabetes mellitus. Nephrol Dial Transplant 20:2472–2478

    Article  PubMed  Google Scholar 

  27. Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C (2009) Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transpl 24:948–955

    Article  CAS  Google Scholar 

  28. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J (2003) Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14:469–477

    Article  PubMed  CAS  Google Scholar 

  29. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y (2002) Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13:1894–1900

    Article  PubMed  Google Scholar 

  30. Kobayashi S, Oka M, Maesato K, Ikee R, Mano T, Hidekazu M, Ohtake T (2008) Coronary artery calcification, ADMA, and insulin resistance in CKD patients. Clin J Am Soc Nephrol 3:1289–1295

    Article  PubMed  Google Scholar 

  31. Jiang N, Qian J, Lin A, Lindholm B, Axelsson J, Yao Q (2008) Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease. Blood Purif 26:423–428

    Article  PubMed  CAS  Google Scholar 

  32. Szeto CC, Chow KM, Kwan BC et al (2007) New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis 49:524–532

    Article  PubMed  CAS  Google Scholar 

  33. de Moraes TP, Pecoits-Filho R (2009) Metabolic impact of peritoneal dialysis. Contrib Nephrol 163:117–123

    Article  PubMed  Google Scholar 

  34. Ammirati AL, Dalboni MA, Cendoroglo M, Draibe SA, Fernandes Canziani ME (2006) Coronary artery calcification, systemic inflammation markers and mineral metabolism in a peritoneal dialysis population. Nephron Clin Pract 104:c33–c40

    Article  PubMed  CAS  Google Scholar 

  35. Stompór TP, Pasowicz M, Sułowicz W, Dembińska-Kieć A, Janda K, Wójcik K, Tracz W, Zdzienicka A, Konieczyńska M, Klimeczek P, Janusz-Grzybowska E (2004) Trends and dynamics of changes in calcification score over the 1-year observation period in patients on peritoneal dialysis. Am J Kidney Dis 44:517–528

    PubMed  Google Scholar 

  36. Chertow GM, Burke SK (2002) Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245–252

    Article  PubMed  CAS  Google Scholar 

  37. Yamada K, Fujimoto S, Nishiura R, Komatsu H, Tatsumoto M, Sato Y, Hara S, Hisanaga S, Ochiai H, Nakao H, Eto T (2007) Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis. Nephrol Dial Transpl 22:2032–2037

    Article  Google Scholar 

  38. Ok E, Asci G, Duman S, Ozkahya M, Ceylan M, Toz H, Faugere MC, Malluche HH (2008) Reduction of calcium exposure slows down progression of vascular calcification and improves adynamic bone disease. Clin J Am Soc Nephrol 3:RB01–RB04: LB005

    Google Scholar 

  39. Bhaskaran S, Schaubel DE, Jassal SV, Thodis E, Singhal MK, Bargman JM, Vas SI, Oreopoulos DG (2000) The effect of small solute clearances on survival of anuric peritoneal dialysis patients. Perit Dial Int 20:181–187

    PubMed  CAS  Google Scholar 

  40. Szeto CC, Wong TY, Chow KM, Leung CB, Law MC, Wang AY, Lui SF, Li PK (2001) Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 12:355–360

    PubMed  CAS  Google Scholar 

  41. Tintut Y, Patel J, Parhami F, Demer LL (2000) Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102:2636–2642

    Article  PubMed  CAS  Google Scholar 

  42. Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, Nishizawa Y (2002) Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91:9–16

    Article  PubMed  CAS  Google Scholar 

  43. Schlieper G, Brandenburg V, Djuric Z, Damjanovic T, Markovic N, Schurgers L, Kruger T, Westenfeld R, Ackermann D, Haselhuhn A, Dimkovic S, Ketteler M, Floege J, Dimkovic N (2009) Risk factors for cardiovascular calcifications in non-diabetic Caucasian haemodialysis patients. Kidney Blood Press Res 32:161–168

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. Evert Dorhout Mees for critical review of the manuscript.

Conflict of interest

All authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ebru Sevinc Ok.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sevinc Ok, E., Asci, G., Kircelli, F. et al. Relationship between glucose exposure via peritoneal dialysis solutions and coronary artery calcification in non-diabetic peritoneal dialysis patients. Int Urol Nephrol 44, 1847–1853 (2012). https://doi.org/10.1007/s11255-012-0138-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-012-0138-8

Keywords

Navigation